Concepedia

Yuqiao Shen

YS

18

Publications

2.6K

Citations

17

H-Index

1993

Active since

Affiliations

BioMarin (United States)(Current)

The University of Texas MD Anderson Cancer Center

Yuqiao Shen is an author at BioMarin (United States) specializing in medicine, tumor biology, and cell biology.

Top concepts

Publications per year

1993–2021

18

Publications

18

BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency

Yuqiao Shen, Farah Rehman, Ying Feng et al. · Clinical Cancer Research · 2013 · 477 citations · Full text

Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity

Clodagh C. O’Shea, Leisa Johnson, Bridget Bagus et al. · Cancer Cell · 2004 · 378 citations · Full text

, , +7

Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition

Junko Murai, Ying Feng, Guoying Karen Yu et al. · Oncotarget · 2016 · 284 citations · Full text

Trapping Poly(ADP-Ribose) Polymerase

Yuqiao Shen, Mika Aoyagi-Scharber, Bing Wang · Journal of Pharmacology and Experimental Therapeutics · 2015 · 225 citations

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

C. Allison Stewart, Pan Tong, Robert J. Cardnell et al. · Oncotarget · 2017 · 221 citations · Full text

, , +17

Rows per page

1–5 of 18